中文

News & Events

dMed Forum in BioBay
2019-03-28Return>>

dMed Forum was held successfully on March 20th in Suzhou BioBay, co-sponsored by dMed Biopharmaceutical Co., Ltd. & Suzhou Industry Park Pharmaceutical Association (SIPPA: http://www.sippa.org.cn/ ).



The event was to help innovative drug/device companies understand the changes of requirements in drug development and life cycle management after China's entry to ICH and solve issues in real life operations. 7 speakers from different functions gave excellent speeches on various aspects of clinical development and held comprehensive discussion with the audience. Topics included product development and registration strategy, the importance of quality management during a clinical trial execution, use of CDISC data standards, the effect of remediation on effectiveness evaluation and example of trial design, the practice of pharmacovigilance in drug life cycle and relevant regulations on medical devices. Although compact, the Forum was instructive on clinical practice.



Participants in the event came from innovative drug R&D and medical device companies in Suzhou and Shanghai. Further cooperation between dMed and BioBay/SIPPA has been confirmed.



298 Xiangke Road, 3/F, 301-305, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201210, China
Tel: +86 21 5090 0085 Fax: +86 21 6875 5515
沪ICP备16041651号-1 Copyright © 2016 dMed All Rights Reserved
沪公网安备 31011502005403号